Supplemental material
Hematology
Volume 27, 2022 - Issue 1
Research Article
Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells
, , , & 
Zhiping Huanga Department of Hematology, Jingzhou Central Hospital, Institute of Hematology, Yangtze University, Jingzhou, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-7165-9019View further author information
https://orcid.org/0000-0002-7165-9019View further author informationRelated Research Data
Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells
Source:
Taylor & Francis
Linking provided by
